Finance

Lists
300942:SHE
Shenzhen Bioeasy Biotechnology Co Ltd
CN¥6.26
-0.79%
(-0.050) 1D
Oct 16, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300942...
Open
CN¥6.39
High
CN¥6.53
Low
CN¥6.20
Mkt. cap
2.69B
Avg. vol.
5.28M
Volume
4.60M
Dividend
0.39%
Quarterly dividend
CN¥0.01
Ex-dividend date
Jun 3, 2026
52-wk high
CN¥11.50
52-wk low
CN¥5.55
EPS
-CN¥0.02
Shares outstanding
405.08M
No. of employees
542
Open
CN¥6.39
High
CN¥6.53
Low
CN¥6.20
Mkt. cap
2.69B
Avg. vol.
5.28M
Volume
4.60M
Dividend
0.39%
Quarterly dividend
CN¥0.01
Ex-dividend date
Jun 3, 2026
52-wk high
CN¥11.50
52-wk low
CN¥5.55
EPS
-CN¥0.02
Shares outstanding
405.08M
No. of employees
542
News stories
From web sources and news partners
About Shenzhen Bioeasy Biotechnology Co Ltd
CEO-
Employees542
FoundedJul 24, 2007
Headquarters-
SectorMedical device
Websitebioeasy.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
76.35M
77.60M
57.64M
70.72M
Cost of goods sold
27.22M
30.92M
25.48M
27.51M
Cost of revenue
27.22M
30.92M
25.48M
27.51M
Research and development expenses
11.22M
10.63M
9.74M
12.20M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
26.87M
29.32M
26.77M
30.36M
Operating expense
38.32M
43.88M
36.28M
42.92M
Total operating expenses
65.54M
74.81M
61.76M
70.42M
Operating income
10.81M
2.79M
-4.12M
299.96K
Other non operating income
3.24M
-3.36M
-6.14M
6.01M
EBT including unusual items
16.34M
-3.70M
-13.09M
-11.07M
EBT excluding unusual items
4.75M
-6.22M
-15.51M
-11.28M
Income tax expense
-574.58K
-358.78K
-2.60M
-2.16M
Effective tax rate
-3.52%
9.70%
19.90%
19.49%
Other operating expenses
26.32K
-109.59K
-898.93K
-1.39M
Net income
15.68M
-4.28M
-10.26M
-9.47M
Net profit margin
20.54%
-5.52%
-17.80%
-13.39%
Earnings per share
-
-
-
-
Interest and investment income
2.03M
2.22M
1.46M
3.24M
Interest expense
-6.91M
-6.82M
-6.72M
-6.79M
Net interest expenses
-4.88M
-4.59M
-5.25M
-3.55M
Depreciation and amortization charges
-
-
-
-
EBITDA
14.14M
10.19M
3.28M
9.22M
Gain or loss from assets sale
171.59K
-12.21M
-
119.59K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps